The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Efficacy and Safety of Sibutramine for Weight Loss: A Systematic Review
Abstract
BACKGROUND: The primary goal of weight loss is to prevent or reduce obesity-associated morbidity and mortality by improving cardiovascular and metabolic risk factors. We conducted a systematic review to assess the efficacy and safety of sibutramine hydrochloride for weight loss. METHODS: In April 2002, we searched MEDLINE, EMBASE, the Cochrane Library, and 7 other computerized bibliographic search tools using the keywords "sibutramine," "Meridia," and "Reductil" (in all languages and all available years). The authors and the manufacturer were contacted. We reviewed randomized placebo-controlled trials of sibutramine, 10 to 20 mg/d, in obese adults. Methodological quality was assessed. RESULTS: A total of 29 trials had sufficient data for analysis after including unpublished data from 10 authors. The summary mean differences in weight loss, sibutramine minus placebo, for the 3-month and 1-year trials were -2.78 kg (95% confidence interval, -2.26 to -3.29 kg) and -4.45 kg (95% confidence interval, -3.62 to -5.29 kg), respectively. The 6-month trials were statistically heterogeneous, and evidence of publication bias was found. One trial found that sibutramine maintains weight loss better than placebo at 2 years. Weight loss with sibutramine was associated with modest increases in heart rate and blood pressure, small improvements in high-density lipoprotein cholesterol and triglycerides levels, and, among diabetic patients, small improvements in glycemic control. There was no direct evidence that sibutramine reduces obesity-associated morbidity or mortality. CONCLUSIONS: Sibutramine is effective in promoting weight loss. Weight loss with sibutramine is associated with both positive and negative changes in cardiovascular and metabolic risk factors. There is insufficient evidence to accurately determine the long-term risk-benefit profile for sibutramine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
(2000) · PubMed · Cited by 13,173
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,780
(1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.899 · Cited by 2,700
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated
Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.309.6965.1351 · Cited by 1,017
US Department of Health & Human Services; Public Health Service; Office of Surgeon General (2001) · PsycEXTRA Dataset · doi:10.1037/e301232004-001 · Cited by 1,001
Petitti, D. B. (1994) · Medical Entomology and Zoology · Cited by 869
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Apfelbaum, M., Vague, P., Ziegler, O., Hanotin, C., Thomas, F., & Leutenegger, E. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00411-2 · Cited by 345
Long-term Weight Loss With Sibutramine: A Randomized Controlled Trial
Wirth, A., & Krause, J. (2001) · JAMA · doi:10.1001/jama.286.11.1331 · Cited by 272
Fujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244
Douketis, J. D., Feightner, J., Attia, J., & Feldman, W. F. (1999) · Europe PMC (PubMed Central) · Cited by 195
Finer, N., Bloom, S. R., Frost, G. S., Banks, L. M., & Griffiths, J. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00071.x · Cited by 171
McNulty, S. J., Ur, E., Williams, G., & For the Multicenter Sibutramine Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.125 · Cited by 166
Smith, I. G., & Goulder, M. A. (2001) · PubMed · Cited by 149
Hansen, D., Toubro, S., Stock, M., Macdonald, I. A., & Astrup, A. V. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801059 · Cited by 148
Anti-obesity drugs: a critical review of current therapies and future opportunities
Clapham, J. C., Arch, J. R., & Tadayyon, M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00105-4 · Cited by 120
Deeks, J. J. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960730)15:14<1601::aid-sim329>3.0.co;2-3 · Cited by 119
A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesity
Fanghänel, G., Cortinas, L., Sánchez‐Reyes, L., & Berber, A. C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801098 · Cited by 114
Dujovne, C. A., Zavoral, J. H., Rowe, E., & Mendel, C. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117510 · Cited by 107
for the STORM study group, Hansen, D., Astrup, A. V., Toubro, S., Finer, N., Kopelman, P., Hilsted, J., Rössner, S. M., Saris, W. H. M., Gaal, L. V., et al. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801481 · Cited by 103
Effects of Sibutramine in Obese Female Subjects With Type 2 Diabetes and Poor Blood Glucose Control
Gökçel, A., Karakose, H., Ertörer, M. E., Tanaci, N., Tütüncü, N. B., & Guvener, N. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1957 · Cited by 100
Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study
Hanotin, C., Thomas, F., Jones, S. W., Leutenegger, É., & Drouin, P. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800540 · Cited by 99
Walsh, K., Leen, E., & Lean, M. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801045 · Cited by 90
Effects of Sibutramine on Resting Metabolic Rate and Weight Loss in Overweight Women
SEAGLE, H. M., Bessesen, D. H., & Hill, J. O. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00324.x · Cited by 89
Absence of Cardiac Valve Dysfunction in Obese Patients Treated with Sibutramine
Bach, D. S., Rissanen, A., Mendel, C. M., Shepherd, G. M., Weinstein, S. P., Kelly, F., Seaton, T. B., Putel, B., Pekkarinen, T., & Armstrong, W. F. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00419.x · Cited by 85
Sramek, J. J., Leibowitz, M. T., Weinstein, S. P., Rowe, E., Mendel, C. M., Levy, B., McMahon, F. G., Mullican, W. S., Toth, P. D., & Cutler, N. R. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001299 · Cited by 79
Serrano‐Ríos, M., Melchionda, N., & Carretero, E. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00655.x · Cited by 73
Hazenberg, B. P. C. (2000) · Cardiology · doi:10.1159/000047310 · Cited by 73
Weight Reduction by Sibutramine in Obese Subjects in Primary Care Medicine: The S. A. T. Study
Hauner, H., Meier, M., Wendland, G., Kurscheid, T., & Lauterbach, K. W. (2004) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2004-817934 · Cited by 72
Zannad, F., Gille, B., Grentzinger, A., Bruntz, J.-F., Hammadi, M., Boivin, J.-M., Hanotin, C., Igau, B., & Drouin, P. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124403 · Cited by 71
Cuellar, G. E. M., Ruiz, A. M., Revilla, M., & Berber, A. C. (2000) · Obesity Research · doi:10.1038/oby.2000.10 · Cited by 67
Pharmacological treatment of obesity: present status
Scheen, A. J., & Lefèbvre, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800795 · Cited by 58
(1996) · PubMed · Cited by 49
O’Meara, S., Riemsma, R. P., Shirran, L., Mather, L., & ter Riet, G. (2002) · Health Technology Assessment · doi:10.3310/hta6060 · Cited by 45
Fanghänel, G., Cortinas, L., Sánchez‐Reyes, L., & Berber, A. C. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801592 · Cited by 38
Long-term weight loss with sibutramine. A randomized controlled trial
Wirth, A. G., & Krause, J. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00555-4 · Cited by 34
Williamson, D. F. (1999) · JAMA · doi:10.1001/jama.281.3.278 · Cited by 25
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension
Faria, A. N., Filho, F. F. R., Lerario, D. D. G., Kohlmann, N. E. B., Ferreira, S. R. G., & Zanella, M. T. (2002) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2002000200006 · Cited by 25
Hensrud, D. D. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70231-5 · Cited by 23
Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension
Fanghänel, G., Cortinas, L., Sánchez‐Reyes, L., Gómez‐Santos, R., Campos-Franco, E., & Berber, A. C. (2003) · Advances in Therapy · doi:10.1007/bf02850257 · Cited by 23
Cited by
The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873
Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Self-citationMetabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679
Salas-Salvadó, J., Rubio, M. A., Barbany, M., & Moreno, B. (2007) · Medicina Clínica · doi:10.1016/s0025-7753(07)72531-9 · Cited by 571
Metadata
- Authors
- Arterburn, D. E., Crane, P. K., & Veenstra, D. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2004-05-10
- Volume
- 164
- Issue
- 9
- Pages
- 994
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2123530223
- Cited by
- 254
- References
- 48
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.